| |
| |
|
| Insider
Information: |
Obrien Christopher Flint |
| Relationship: |
Former Chief Medical O... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
55,946 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$7,798,872 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
55,946 |
|
|
| Total
Value |
$7,798,872 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Former Chief Medical O... |
2018-02-06 |
55,946 |
2008-09-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-01-10 |
4 |
AS |
$43.35 |
$75,863 |
D/D |
(1,750) |
31,794 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2016-01-11 |
4 |
AS |
$44.25 |
$77,438 |
D/D |
(1,750) |
126,794 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2013-09-03 |
4 |
AS |
$16.00 |
$80,000 |
D/D |
(5,000) |
94,794 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2016-01-19 |
4 |
AS |
$46.77 |
$81,848 |
D/D |
(1,750) |
128,544 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Former Chief Medical Officer |
• – – |
2018-02-06 |
4 |
D |
$82.48 |
$83,635 |
D/D |
(1,014) |
55,946 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr. VP & Chief Medical Officer |
• – – |
2011-02-28 |
4 |
AS |
$6.83 |
$84,091 |
D/D |
(12,320) |
94,794 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2014-01-07 |
4 |
AS |
$17.50 |
$87,500 |
D/D |
(5,000) |
94,794 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2013-06-28 |
4 |
AS |
$13.50 |
$101,250 |
D/D |
(7,500) |
94,794 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2014-11-24 |
4 |
AS |
$19.53 |
$106,692 |
D/D |
(5,463) |
96,544 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2014-01-10 |
4 |
AS |
$18.55 |
$127,463 |
D/D |
(6,750) |
96,544 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2018-01-16 |
4 |
AS |
$79.14 |
$138,499 |
D/D |
(1,750) |
50,723 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2015-01-08 |
4 |
OE |
$2.59 |
$142,450 |
D/D |
55,000 |
111,544 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2013-06-21 |
4 |
AS |
$12.50 |
$187,861 |
D/D |
(14,926) |
94,794 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Former Chief Medical Officer |
• – – |
2018-02-05 |
4 |
AS |
$83.01 |
$217,341 |
D/D |
(2,613) |
54,310 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2014-11-17 |
4 |
AS |
$19.51 |
$220,463 |
D/D |
(11,300) |
96,544 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2013-06-20 |
4 |
AS |
$12.20 |
$261,386 |
D/D |
(21,217) |
94,794 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2014-11-10 |
4 |
AS |
$18.62 |
$372,400 |
D/D |
(20,000) |
96,544 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2015-06-01 |
4 |
AS |
$42.20 |
$422,000 |
D/D |
(10,000) |
100,044 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-10-02 |
4 |
AS |
$61.04 |
$422,702 |
D/D |
(6,925) |
48,973 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2014-12-10 |
4 |
AS |
$21.55 |
$433,750 |
D/D |
(20,125) |
96,544 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-07-27 |
4 |
AS |
$50.00 |
$436,700 |
D/D |
(8,734) |
48,973 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2014-12-11 |
4 |
AS |
$22.10 |
$439,238 |
D/D |
(19,875) |
95,644 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2015-06-08 |
4 |
AS |
$45.00 |
$450,000 |
D/D |
(10,000) |
100,044 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-11-02 |
4 |
OE |
$8.65 |
$457,320 |
D/D |
52,817 |
56,491 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Medical Officer |
• – – |
2017-09-05 |
4 |
OE |
$8.66 |
$457,395 |
D/D |
52,817 |
101,790 |
0 |
- |
|
65 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
